SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-08-002685
Filing Date
2008-05-12
Accepted
2008-05-12 16:44:49
Documents
10
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c73357e10vq.htm 10-Q 385104
2 EXHIBIT 10.1 c73357exv10w1.htm EX-10.1 39615
3 EXHIBIT 10.2 c73357exv10w2.htm EX-10.2 13091
4 EXHIBIT 10.3 c73357exv10w3.htm EX-10.3 6026
5 EXHIBIT 10.4 c73357exv10w4.htm EX-10.4 117570
6 EXHIBIT 10.5 c73357exv10w5.htm EX-10.5 11534
7 EXHIBIT 31.1 c73357exv31w1.htm EX-31.1 5788
8 EXHIBIT 31.2 c73357exv31w2.htm EX-31.2 6328
9 EXHIBIT 32.1 c73357exv32w1.htm EX-32.1 2395
10 EXHIBIT 32.2 c73357exv32w2.htm EX-32.2 2627
  Complete submission text file 0001362310-08-002685.txt   591448
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
Type: 10-Q | Act: 34 | File No.: 000-16132 | Film No.: 08823780
SIC: 2834 Pharmaceutical Preparations